Concurrent Corporate Partner Breakout SessionsHarness the learning from collaborative partnerships within these 60-minute breakout sessions. The content is pre-recorded, with opportunity for live engagement through interactive chart and Q&A for attendees to learn more from AMGA Corporate Partners and AMGA Members on the topic presented.
Day 1: Innovations in Health Care
Tuesday, April 20, 3:00 p.m. – 4:00 p.m.
Conducting a Fully Digital Trial During a Pandemic
Estimates suggest more than 1,300 clinical trials were negatively impacted by COVID-19 in 2020, further increasing the urgency for disruption and digitization in the clinical trial space. Learn how the Optum Digital Research Network is partnering with healthcare organizations to redefine trial processes. This presentation will detail a fully digital clinical study that utilized a combination of robust data assets and cutting-edge technology to identify eligible patients, provided a path to pivot from in-person to online enrollment to accommodate COVID-19 office visit restrictions, and decreased research site burden through sourcing trial data directly from the EMRs of three separate research sites into an electronic data capture (EDC) system with no need for any manual data transcription.
Beyond A1C: How Continuous Glucose Monitoring Data Can Improve Diabetes Outcomes
Learn how real-time continuous glucose monitoring (RT-CGM) data can support healthcare professionals to optimize diabetes treatment, support healthy behavior changes in people with diabetes, and improve diabetes outcomes.
Day 2: Patient Care and Experience
Wednesday, April 21, 3:00 p.m. – 4:00 p.m.
One Yes at a Time: Health Systems Take on Suboptimal Colorectal Cancer Screening Rates
Breaking down barriers that keep people from participating in colorectal cancer (CRC) screening may help mitigate the negative impact of this preventable disease. Colorectal cancer is on the rise, with younger populations increasingly at risk. Finding a screening test that patients will complete can be challenging, but there are more options now than ever before. During the panel discussion, presenters will discuss why screening for CRC is still imperative during this uncertain time, present data on their quality improvement journeys, and share effective strategies for improving CRC screening rates. The audience will learn about technology enablement tools and how they may help optimize workflows and enhance patient engagement. In addition, they will explore how shared decision-making, in combination with a portfolio of different CRC screening options, may help more patients complete this very important preventive screening.
Coaching Clinicians: A Path to Engagement and ImprovementStephen Beeson, M.D., CEO and Founder, The Clinician Experience Project
As we say, “As your clinicians go…so goes your group.” In this session, we will outline the power of creating a coaching culture to advance the experience of patients, the engagement of clinicians, and the effectiveness of leaders. We will review how coaching and development fuels outcomes, discuss the design of an enterprise coaching strategy, and share practical examples of how AMGA members are scaling coaching to create a mastery culture that fuels impact, clinician vitality, and measurable results.
Participants in this session will be able to:
- Describe why the performance of clinicians is critical to group performance
- Explain the results of coaching clinicians to advance both wellness and performance
- Describe how to set-up an enterprise coaching system that supports clinicians and improves organizational outcomes
Day 3: Organizational Resiliency
Thursday, April 22, 3:00 p.m. – 4:00 p.m.
Are You IN or OUT? Outpatient Management of Low-Risk PE Patients
Pulmonary embolisms (PEs) are a major health concern in the U.S. with an economic burden of more than $8.5 billion annually. This presentation will provide an overview of the prevalence of PE in the U.S., examples of low-risk PE protocols/algorithms, scoring tools for risk stratification of patients, and potential barriers to outpatient protocol development. Attendees will learn how some health systems are managing outpatient venous thromboembolism (VTE) in the ED, recognize strategies to identify low-risk PE patients, and describe potential barriers to outpatient protocol development.
Healthcare Consumerism’s Tipping Point: Why COVID-19-Related Shifts in Patients’ Preferences Are Here to Stay
In this panel discussion session, medical group leaders will share their first-hand perspectives on the impact that the COVID-19 pandemic has had on patients’ preferences and expectations and how it has accelerated the move toward consumerism. For instance, a recent Accenture report found that, “The pandemic has led to new standards for consumer needs that may remain long after the crisis has passed.” We’ll explore how these patient-centric shifts toward convenience, flexibility, personalization and technology-enabled experiences are likely here to stay—and how medical groups can align with them. We will also share survey data from Phreesia’s network illustrating patients’ evolving preferences.